Clinical trial
Merkel Cell Carcinoma Clinical Trials: What Are Prevailing Patient Experiences in Merkel Cell Carcinoma Studies
NCT06039033 is registered in ClinicalTrials.gov with Power Life Sciences Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Merkel Cell Carcinoma Clinical Trials: What Are Prevailing Patient Experiences in Merkel Cell Carcinoma Studies
- Lead sponsor
- Power Life Sciences Inc.
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- October 31, 2024
- Completion date
- October 31, 2026
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
merkel cell carcinoma